Capital International Investors Has $460.19 Million Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Capital International Investors lessened its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 7.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,581,123 shares of the company's stock after selling 133,603 shares during the quarter. Capital International Investors owned about 2.76% of Molina Healthcare worth $460,186,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Tributary Capital Management LLC grew its holdings in Molina Healthcare by 76.1% during the 4th quarter. Tributary Capital Management LLC now owns 4,190 shares of the company's stock valued at $1,219,000 after purchasing an additional 1,811 shares in the last quarter. Everence Capital Management Inc. acquired a new position in shares of Molina Healthcare in the fourth quarter worth about $544,000. Smartleaf Asset Management LLC boosted its holdings in Molina Healthcare by 123.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock valued at $100,000 after purchasing an additional 192 shares during the last quarter. SYM FINANCIAL Corp acquired a new stake in Molina Healthcare during the 4th quarter valued at approximately $249,000. Finally, Oddo BHF Asset Management Sas purchased a new stake in Molina Healthcare during the 3rd quarter worth approximately $2,947,000. Hedge funds and other institutional investors own 98.50% of the company's stock.

Molina Healthcare Trading Down 5.2 %

MOH stock traded down $17.22 during mid-day trading on Thursday, reaching $314.78. 736,157 shares of the stock traded hands, compared to its average volume of 669,722. The stock's fifty day moving average is $317.63 and its 200-day moving average is $307.82. The company has a market cap of $17.22 billion, a P/E ratio of 15.45, a P/E/G ratio of 1.06 and a beta of 0.70. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $370.99.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping the consensus estimate of $5.86 by $0.22. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The firm had revenue of $11.15 billion for the quarter, compared to analysts' expectations of $10.86 billion. During the same period in the previous year, the company posted $5.73 EPS. As a group, sell-side analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Insider Activity

In related news, Director Steven J. Orlando sold 1,000 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the transaction, the director now directly owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.10% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

MOH has been the subject of a number of recent analyst reports. Mizuho raised their price target on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Wells Fargo & Company upgraded shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $295.00 to $372.00 in a research note on Wednesday, March 5th. UBS Group decreased their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Barclays cut their price objective on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research note on Friday, February 7th. Finally, Stephens reiterated an "equal weight" rating and issued a $345.00 target price on shares of Molina Healthcare in a research report on Thursday, February 6th. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $363.62.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.